{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05819138",
            "orgStudyIdInfo": {
                "id": "22-0794"
            },
            "secondaryIdInfos": [
                {
                    "id": "R01HL165433",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/R01HL165433"
                }
            ],
            "organization": {
                "fullName": "University of Colorado, Denver",
                "class": "OTHER"
            },
            "briefTitle": "Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes",
            "officialTitle": "Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes",
            "acronym": "T1-DISCO",
            "therapeuticArea": [
                "Endocrinology"
            ],
            "study": "type-diabetes-impacts-of-semaglutide-on-cardiovascular-outcomes"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-06-21",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-10",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-04-04",
            "studyFirstSubmitQcDate": "2023-04-04",
            "studyFirstPostDateStruct": {
                "date": "2023-04-19",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-14",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-16",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Colorado, Denver",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Heart, Lung, and Blood Institute (NHLBI)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This trial plans to learn more about the effects of a medication, semaglutide, on cardiovascular function, kidney function, and insulin sensitivity in adults with type 1 diabetes. This medication has been effective in reducing cardiovascular disease and diabetic kidney disease and improving glucose control and BMI in adults with type 2 diabetes. This study aims to look at how well the medication works in people with type 1 diabetes. Semaglutide is not approved by the FDA to be used in this way. These procedures are considered to be experimental."
        },
        "conditionsModule": {
            "conditions": [
                "Diabetes Mellitus, Type 1"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Semaglutide",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive 0.25 mg once weekly semaglutide injection for 4 weeks.\n\nParticipants will receive 0.50 mg once weekly semaglutide injection for 4 weeks.\n\nParticipants will receive 1.0 mg once weekly semaglutide injection for 6 months.",
                    "interventionNames": [
                        "Drug: Semaglutide Pen Injector"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Participants will receive 0.25 mg once weekly placebo injection for 4 weeks. Participants will receive 0.50 mg once weekly placebo injection for 4 weeks. Participants will receive 1.0 mg once weekly placebo injection for 6 months.",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Semaglutide Pen Injector",
                    "description": "Semaglutide injection",
                    "armGroupLabels": [
                        "Semaglutide"
                    ],
                    "otherNames": [
                        "Ozempic"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Semaglutide placebo injection",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in Ascending Aortic Pulse Wave Velocity (AA PWV)",
                    "description": "AA PWV is a measure of central arterial stiffness. A lower value indicates a better outcome.",
                    "timeFrame": "Baseline, month 8"
                },
                {
                    "measure": "Change in Carotid and Femoral Artery Pulse Wave Velocity (CF-PWV)",
                    "description": "CF-PWV is a measure of peripheral arterial stiffness. A lower value indicates a better outcome.",
                    "timeFrame": "Baseline, month 8"
                },
                {
                    "measure": "Change in Carotid and Radial Artery Pulse Wave Velocity (CR-PWV)",
                    "description": "CR-PWV is a measure of peripheral arterial stiffness. A lower value indicates a better outcome.",
                    "timeFrame": "Baseline, month 8"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in Insulin Sensitivity",
                    "description": "Insulin Sensitivity is a measure of how well the body responds insulin. A higher value indicates a better outcome; a lower value indicates a worse outcome.",
                    "timeFrame": "Baseline, month 8"
                },
                {
                    "measure": "Change in Renal Vascular Resistance (RVR)",
                    "description": "RVR is a measure of mean arterial pressure to renal blood flow. A higher value indicates a worse outcome.",
                    "timeFrame": "Baseline, month 8"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age 18-49 years\n* 1) T1D diagnosis defined as diabetes \\<30 years duration plus positive T1D-associated antibody(ies) or 2) a clinical diagnosis of T1D plus insulin requirement since diagnosis, \\<30 years duration\n* Insulin pump or automated insulin delivery systems\n* Estimated glomerular filtration rate (eGFR) \u2265 45 ml/min/1.73m2\n* Stable doses of drugs altering cardiovascular and renal function (e.g., Angiotensin-Converting Enzyme Inhibitor (ACEi), Angiotensin Receptor Blocker (ARB), statins, diuretics)\n* BMI 20-45 kg/m2\n* Adequate contraceptive method for females\n\nExclusion Criteria:\n\n* HbA1c \\>9%, recent diabetic ketoacidosis (DKA) or hospitalization\n* Major congenital heart disease, anemia, severe non-proliferative retinopathy, proliferative retinopathy\n* History/family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2 (MEN2), pancreatitis\n* Current/planned pregnancy or nursing\n* Uncontrolled thyroid disease or hypertension (HTN) (\u2265 160/100 mm Hg despite optimal therapy)\n* Use of other non-insulin diabetes medications, insulin sensitizing medications, or systemic steroids in past 3 months\n* Use of atypical antipsychotics\n* Significant systemic illness such as cancer\n* Shellfish/iodine allergy (only exclusionary to iohexol clearance procedure)\n* MRI or PAH contraindications (only exclusionary to MRI and PAH procedures), GLP-1RA allergy",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "49 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Kyla Best",
                    "role": "CONTACT",
                    "phone": "720-777-9500",
                    "email": "Kyla.Best@cuanschutz.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Petter M Bjornstad, MD",
                    "affiliation": "University of Colorado - Anschutz Medical Campus",
                    "role": "PRINCIPAL_INVESTIGATOR"
                },
                {
                    "name": "Kristen Nadeau, MD, MS",
                    "affiliation": "University of Colorado - Anschutz Medical Campus",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Colorado Anschutz Medical Campus",
                    "status": "RECRUITING",
                    "city": "Aurora",
                    "state": "Colorado",
                    "zip": "80045",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kyla Best",
                            "role": "CONTACT",
                            "phone": "720-777-9500",
                            "email": "Kyla.Best@cuanschutz.edu"
                        },
                        {
                            "name": "Petter Bjornstad, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        },
                        {
                            "name": "Kristen Nadeau, MD, MS",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.72943,
                        "lon": -104.83192
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000003922",
                    "term": "Diabetes Mellitus, Type 1"
                }
            ],
            "ancestors": [
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7117",
                    "name": "Diabetes Mellitus, Type 1",
                    "asFound": "Diabetes Mellitus, Type 1",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "asFound": "Diabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000591245",
                    "term": "Semaglutide"
                }
            ],
            "ancestors": [
                {
                    "id": "D000097789",
                    "term": "Glucagon-Like Peptide-1 Receptor Agonists"
                },
                {
                    "id": "D000007004",
                    "term": "Hypoglycemic Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M353561",
                    "name": "Semaglutide",
                    "asFound": "Stretching",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9043",
                    "name": "Glucagon",
                    "relevance": "LOW"
                },
                {
                    "id": "M26997",
                    "name": "Glucagon-Like Peptide 1",
                    "relevance": "LOW"
                },
                {
                    "id": "M3401",
                    "name": "Glucagon-Like Peptide-1 Receptor Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M10054",
                    "name": "Hypoglycemic Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Hypo",
                    "name": "Hypoglycemic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                }
            ]
        }
    },
    "hasResults": false
}